Comparison of A2M, BAL and BKL

Just do some numbers for the comparison among A2M, BAL and BKL(Blackmore) with the information digested from their respective ASX announcements....

Company(ASX Code) A2M BAL BKL

Total Issued Shares (FPOs), millions 703.56 96.63 17.23
EBIT, $millions 72.3 12.3 35.0(this is EBITDA, avg of 33~37)
EPS (Ear per share, $/per share) 2.702 0.098 0.036 (assume 70% of EBITDA as net Profit)
Closed Share Price on 22 Dec 2015 210.0 14.31 1.545
P/E (Share Price/ EPS) 77.72 146.02 42.92

The P/E figures are the ones which are normally regarded as the gold standard to investment and apparently investors have currently given all three a high P/E ratio, implying (or predicting or hoping) all three will continue to grow very fast (SRX's P/E is 47.2) and therefore the E will become bigger and therefore the P/E ratio will then go down and such company will become more "mature company. The P/E ratio of Sigma Pharma (SIP) is around 15.2 and ANZ is 10.0, respectively

In mathematics, if BKL is the golden example, then BAL needs to grow twice as fast as it is now to bring to P/E to BKL's level; on the other hand, A2M's share price might go up to 2.80 (=1.545*77.72/42.92), if A2M could enjoy the higher P/E ration which BKL has now.